目的探讨母儿abo血型不合的孕期治疗以及分娩前母体血清抗体效价与新生儿黄疸程度的关系。
Objective: To study the treatment during pregnancy and the relation between maternal serum antibody titer and jaundice degree of the newborn of maternal-fetal ABO blood group incompatibility.
结论莲黄汤治疗母儿ABO血型不合有较好的疗效，能有效降低其血清抗体效价，预防产后新生儿ABO溶血病的发生。
ConclusionLHD has good clinical curative effect in treating FM-ABOI, could decrease the serum antibody titer, and prevent the occurrence of postpartum hemolytic disease in newborns.
结论莲黄汤治疗母儿ABO血型不合有较好的疗效，能有效降低其血清抗体效价，预防产后新生儿ABO溶血病的发生。
ConclusionLHD has good clinical curative effect in treating FM-ABOI, could decrease the serum antibody titer, and prevent the occurrence of postpartum hemolytic disease in newborns.
应用推荐